斯皮仁诺
- Sporanox
-
方法:8例轻度角膜炎单服斯皮仁诺。
Methods : Eight patients with mild keratitis were treated only with sporanox .
-
结论加用斯皮仁诺治疗复发性阴道念珠菌病效果明显,是一种有效的治疗方法。
Conclusion plus with Sporanox treatment of recurrent vaginal candidiasis evident result is an effective treatment .
-
结论盐酸伊曲康唑分散片的平均相对生物利用度为142.29%,较斯皮仁诺有明显提高(P<0.05),双单侧t检验的结果表明两制剂的lnAUC0-48和lnρmax均为生物不等效。
CONCLUSION The mean relative bioavailability is 142.29 % . The AUC of the dispersible tablets are significantly higher than that of capsules ( P < 0.05 ) . The test and reference formulations are not bioequivalent .
-
斯皮仁诺短程冲击间歇治疗老年甲真菌病
Treatment of onychomycosis with sporanox by short-phase pulse therapy in elderly
-
真菌感染对氟康唑耐药增多,对斯皮仁诺仍敏感。
Fungal infection was more resistant to fluconazole , but was sensitive to itraconazole .
-
达克宁栓与斯皮仁诺联合治疗复发性念珠菌性阴道炎的疗效观察
Observations on the Combined Therapeutic Effect of Miconazole Nitrate Pessary and Itraconazole on Recurrent Candidal Vaginitis
-
总结斯皮仁诺治疗造血系统恶性疾病继发真菌感染患者的护理体会。
The authors summarize their experience in nursing the patients with fungus infections from malignant diseases in hematopoietic system treated with Sporanox .
-
目的:考察伊曲康唑(商品名斯皮仁诺)在皮肤真菌性疾病治疗剂量下的药物安全性。
Objective To study the security of Itraconazole ( commercial name is Sporanox ) in the treatment of fungal disease under treatment dose .
-
斯皮仁诺、氟康唑治疗187例念珠菌性尿道炎的临床治愈率、细菌学治愈率分别为77.71%、95.18%和80.95%、90.48%。
Clinical cure rate and fungal clearance rate of candidal urethritis treated with itraconazole vs fluconazole were 77.71 % and 95.18 % vs 80.95 % and 90.48 % .